Retrograde Axonal Transport of Transmitter Enzymes, Fucose-Labeled Protein, and Nerve Growth Factor in Streptozotocin-Diabetic Rats

Rapid axonal transport was studied by several methods in rats with serum glucose levels above 300 mg/dl as a result of treatment with streptozotocin (45–50 mg/kg) 3 days, 1 wk, 4 wk, 8 wk, or 4 mo earlier. With untreated age-matched rats as controls, rapid anterograde axonal transport in the sciatic nerves of diabetic rats appeared entirely normal. Statistically significant differences were never observed between experimental and control nerves in the basal content of acetylcholinesterase (AChE) and dopamine-β-hydroxylase (DBH) activity or in the rate of accumulation of these enzymes proximal or distal to a ligature. Therefore, the basic capacity for rapid anterograde and retrograde axonal transport of proteins was probably unimpaired in the diabetic nerves. The accumulation of labeled glycoproteins proximal to ligatures on the contralateral nerves of the same rats after injection of the L5 dorsal root ganglion with 3H-fucose was likewise normal. However, rats with 1, 4, and 8 wk of diabetes did show reduced accumulation of fucose-labeled protein distal to nerve ligations, indicating a long-lasting abnormality of retrograde axonal transport. Furthermore, this abnormality was reversed by daily insulin treatment during the second half of an 8-wk experimental period. It is therefore unlikely that the depression of retrograde transport reflects direct toxic effects of streptozotocin. We conclude that streptozotocin-induced diabetes leads to: (1) abnormal delay in the turnaround of transported proteins in distal nerve regions, perhaps combined with (2) an abnormal metabolism of glycoproteins. A delayed onset of retrograde transport is consistent with present observations of reduced accumulation of 125I-labeled nerve growth factor (NGF) below a midthigh ligature on the sciatic nerve after injection of this protein into the hindfoot of rats with 3–5 wk of diabetes. Further work on the factors controlling rapid retrograde transport of proteins in diabetic nerve is warranted.

[1]  A. Windebank,et al.  Interstitial Hyperosmolarity May Cause Axis Cylinder Shrinkage in Streptozotocin Diabetic Nerve , 1980, Journal of neuropathology and experimental neurology.

[2]  Eugene M. Johnson,et al.  Effects of long-term nerve growth factor deprivation on the nervous system of the adult rat: An experimental autoimmune approach , 1980, Brain Research.

[3]  J. Jakobsen,et al.  Decreased axonal transport of structural proteins in streptozotocin diabetic rats. , 1980, The Journal of clinical investigation.

[4]  M. Bisby.  Axonal transport of labeled protein and regeneration rate in nerves of streptozocin-diabetic rats , 1980, Experimental Neurology.

[5]  J. Jakobsen,et al.  Reduced Perikaryal Volume of Lower Motor and Primary Sensory Neurons in Early Experimental Diabetes , 1980, Diabetes.

[6]  H. Thoenen,et al.  Nerve Growth Factor: Biological Significance, Measurement and Distribution , 1980, Journal of neurochemistry.

[7]  S. Brimijoin,et al.  Axonal transport of dopamine-β-hydroxylase and acetylcholinesterase in human peripheral neuropathy , 1979, Experimental Neurology.

[8]  E. Johnson,et al.  Experimental autoimmune model of nerve growth factor deprivation: effects on developing peripheral sympathetic and sensory neurons. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[9]  J. Jakobsen,et al.  Axonal transport in early experimental diabetes , 1979, Brain Research.

[10]  R. Harris-Warrick,et al.  Nerve growth factor receptors. Characterization of two distinct classes of binding sites on chick embryo sensory ganglia cells. , 1979, The Journal of biological chemistry.

[11]  J. Jakobsen,et al.  Early and preventable changes of peripheral nerve structure and function in insulin-deficient diabetic rats. , 1979, Journal of neurology, neurosurgery, and psychiatry.

[12]  S. Brimijoin,et al.  Rapid orthograde and retrograde axonal transport of acetylcholinesterase as characterized by the stop‐flow technique. , 1978, The Journal of physiology.

[13]  M. Bisby,et al.  REVERSAL OF AXONAL TRANSPORT AT A NERVE CRUSH 1 , 1977, Journal of neurochemistry.

[14]  E. Shooter,et al.  Characterization and isolation of proteolytically modified nerve growth factor. , 1976, Biochemistry.

[15]  D. A. Godfrey,et al.  Fast and Slow Axoplasmic Flow in Sciatic Nerve of Diabetic Rats , 1975, Diabetes.

[16]  M. Schwab,et al.  Specificity of retrograde transport of nerve growth factor (NGF) in sensory neurons: A biochemical and morphological study , 1975, Brain Research.

[17]  P. Molinoff,et al.  A sensitive enzymatic assay for dopamine- -hydroxylase. , 1971, The Journal of pharmacology and experimental therapeutics.

[18]  E. Fenton.  Tissue culture assay of nerve growth factor and of the specific antiserum. , 1970, Experimental cell research.

[19]  L. Potter.  A radiometric microassay of acetylcholinesterase. , 1967, The Journal of pharmacology and experimental therapeutics.

[20]  S. Eliasson.  NERVE CONDUCTION CHANGES IN EXPERIMENTAL DIABETES. , 1964, The Journal of clinical investigation.

[21]  D. W. Mulder,et al.  The neuropathies associated with diabetes mellitus: A clinical and electromyographic study of 103 unselected diabetic patients , 1961 .